FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
07-01-2017, 02:13 PM | #1 | |||
|
||||
Grand Magnate
|
MT Pharma America Enrolls More Than 700 Sites of Care in Newly Created National Infusion Center Directory for ALS Patients
MT Pharma America Enrolls More Than 7 Sites of Care in Newly Created National Infusion Center |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
MT Pharma America Presents 12-Month RADICAVA™ (Edaravone) and Amyotrophic Lateral Scl | ALS News & Research | |||
MT Pharma America Presents 12-Month RADICAVAtm(Edaravone) and Amyotrophic Lateral Scl | ALS News & Research | |||
MT Pharma America Announces FDA Approval of RADICAVAtm (Edaravone), the First New Tre | ALS News & Research | |||
Health Care in America (Political Blues) | Reflex Sympathetic Dystrophy (RSD and CRPS) |